Ratings by Craig-Hallum (Per Ostlund)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/16/2025 | icad Inc. | ICAD | Downgrade | Hold (Buy) |
1.93 (3.87) |
100.52% | Details | |
| 1/13/2025 | Natera | NTRA | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2024 | Natera | NTRA | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2024 | Natera | NTRA | New Coverage | Buy (N/A) |
96.75 (198.13) |
104.79% | Details | |
| 5/16/2023 | icad Inc. | ICAD | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2023 | icad Inc. | ICAD | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | icad Inc. | ICAD | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | icad Inc. | ICAD | Maintain | Buy (N/A) |
|
Details | ||
| 12/6/2021 | icad Inc. | ICAD | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2020 | Chembio Diagnostics | CEMI | Upgrade | Buy (Hold) |
7.04 (0.46) |
-93.47% | Details | |
| 6/17/2020 | Chembio Diagnostics | CEMI | Maintain | Hold (N/A) |
|
Details | ||
| 6/17/2020 | Chembio Diagnostics | CEMI | Downgrade | Hold (Buy) |
9.93 (0.46) |
-95.37% | Details | |
| 7/10/2019 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2018 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details |
